ItaCRIN support can be provided to any project submitted to European calls dedicated to multinational clinical research such as Horizon 2020 (H2020), the Innovative Medicines Initiative (IMI), the European and Developing Countries Clinical Trial Partnership (EDCTP), the European Research Area Networks (ERA-Net) for rare diseases (E-Rare), cancer (ERA-Net TRANSCAN), neurosciences (ERA-Net NEURON), Personalized Medicine (ERA PerMed).
ECRIN can provide support services even if the trial’s coordinating country is not a member or observer, provided that the project involves at least two member and observer countries. In this case, one of ECRIN’s EuCos or the core team is assigned to the trial. However, countries that are not members or observers cannot benefit from support for trial preparation.
For general information on multinational clinical trial funding, click here (https://www.ecrin.org/node/520).